A new study has identified sildenafil — an FDA-approved therapy for erectile dysfunction (Viagra) and pulmonary hypertension (Ravatio) — as a promising drug candidate to help prevent and treat Alzheimer’s disease. Researchers determined that sildenafil is associated with 69% reduced incidence of Alzheimer’s.